Faecal transplant ‘might halt beta-cell decline’ in early T1DM

A small randomised controlled trial suggests autologous transplants work best
Reuters Health Staff writer

Faecal microbiota transplantation can stop the functional decline of islet beta cells in adults with new-onset type 1 diabetes mellitus (T1DM), a small trial suggests.

Dutch researchers investigated whether autologous faecal microbiota transplants (FMTs) or allogenic FMTs from healthy donors would affect beta-cell function, as measured by C-peptide levels, in 20 patients with diabetes diagnosed less than six weeks prior.